StockSelector.com
  Research, Select, & Monitor Tuesday, April 23, 2019 2:41:48 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
CTI BioPharma Corp.$1.01$.066.32%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

CTI BioPharma Corp. has an overall rank of 6499 out of 6863 stocks based on 5 positive rankings and 11 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $4.00 for CTI BioPharma using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, CTI BioPharma is ranked 9.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, CTI BioPharma is ranked 388.
Oversold Stochastics
CTI BioPharma rank is 415
Price-to-Book
CTI BioPharma rank is 987
Debt-to-Equity
CTI BioPharma rank is 1409
Negative Rankings
90 Day Loss
CTI BioPharma rank is 273
Negative Cash Growth
CTI BioPharma rank is 286
Negative Net Margin
CTI BioPharma rank is 461
Negative Revenue Growth
CTI BioPharma rank is 538
Negative ROE
CTI BioPharma rank is 574
Negative ROA
CTI BioPharma rank is 687
10 Day Loss
CTI BioPharma rank is 819
High Put/Call
CTI BioPharma has a high Put/Call ratio of 0.87 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, CTI BioPharma is ranked 1101.
High vPut/Call
CTI BioPharma has a high Put/Call ratio of 0.86 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, CTI BioPharma is ranked 1486.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, CTI BioPharma is ranked 1498.
Price-to-Sales
CTI BioPharma rank is 2314







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.